Member Login
  1. Stocks
    2. /
  2. Gilead Sciences (NASDAQ: GILD)
    3. /

NASDAQ:GILD (Gilead Sciences)

About GILD

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Gilead Sciences (NASDAQ: GILD) Latest News

    Coronavirus

    Will Remdesivir Save the Economy — and the World?

    | Aditya Raghunath

    Will Gilead's wonder drug save millions of lives and send equity markets higher?

    Read more »

    Investing

    Coronavirus Fears Make This Stock a Winner

    | Cindy Dye

    Even as the broader market has plunged this week, one stock has benefitted from the news regarding the disease.

    Read more »

    Tech Stocks

    Is iShares Nasdaq Biotechnology Index Fund a Buy?

    | Nicholas Rossolillo

    If you lack the time or technical knowledge to invest in biotech, this might be the fund for you and…

    Read more »

    Dividend Stocks

    2 Discounted Dividend Stocks for Your RRSP

    | Kay Ng

    Build a nest egg in your RRSP today without the hindrance of taxes. Consider quality and discounted dividend stocks such…

    Read more »

    Investing

    Why These 3 Canadian Small-Cap Names Are up 150% This Year (and Poised to Continue)

    | Adam Mancini

    Driven by their close exposure to oil prices, small caps Baytex Energy Corp. (TSX:BTE)(NYSE:BTE), Lithium X Energy Corp. (TSX:LIX), and…

    Read more »